ETL-Driven Data Integration for Enhanced Pharmaceutical Manufacturer Rebate Processing

Authors

  • Venkat Sunil Kumar Indurthy Software Developer, Compunnel Software Group Inc, USA Author

DOI:

https://doi.org/10.15662/9cfsb587

Keywords:

Pharmaceutical rebates, eRebate, ETL data pipelines, Informatica PowerCenter, SnapLogic

Abstract

Pharmaceutical rebates are monetary incentives that are paid to payers (even health plan and pharmacy benefit managers) by a drug manufacturer in an effort to reduce drug cost and enhance availability in the marketplace. Rebates can be based on performance, volume, or other elements related to the drug manufacturers' pharmaceutical data about prescribers and practices, and span the range of levels of prescribing, formulary placement, and total healthcare spending. The eRebate platform allows pharmaceutical manufacturers and their wholesale distributors to do an automated management of rebates by providing visibility to rebate contracts, by checking and monitoring the information accurately, and payment is processed. Overall, business operations are more efficient and there is enhanced transparency. This is all accomplished through rigorous ETL data pipelines that gather, transform, and centralize drug manufacturer and payer data using software tools such as Informatica PowerCenter and SnapLogic. The eRebate methodology involves making iterative changes to be able to practice agile governance and data quality. As automated workflows and enhanced troubleshooting processes are established, manufacturers and their trading partners will have the means to successfully manage burdening processing of rebate data in order to issue refunds and conduct analysis that are useful for data-driven decisions to effectively administer rebates.

References

1. “Driving Efficiency in the Pharmaceutical Industry: Managing Rebates with EDI”, November 20, 2023, https://www.truecommerce.com/blog/driving-efficiency-in-the-pharmaceutical-industry-managing-rebates-with-edi/.

2. “SAP Business Network Supplier Administration Guide”, 2025, https://help.sap.com/doc/b7427a56febd476d90d4357562a2ffe2/2508/en-US/ManagingSellerAccount_1.pdf.

3. “The Principle of Least Privilege Explained (with Best Practices)”, Muhammad Raza, June 20, 2023, https://www.splunk.com/en_us/blog/learn/least-privilege-principle.html.

4. “A primer on prescription drug rebates: Insights into why rebates are a target for reducing prices”, Maggie Alston, Gabriela Dieguez, Samantha Tomicki, 21 May 2018, https://www.milliman.com/en/insight/a-primer-on-prescription-drug-rebates-insights-into-why-rebates-are-a-target-for-reducing.

5. “Contracting over Rebates: Formulary Design and Pharmaceutical Spending”, Kate Ho, Robin S. Lee, October 2023, https://kateho.scholar.princeton.edu/sites/g/files/toruqf4136/ files/documents/20231019_Formulary_Design.pdf.

6. “Recent Research Reveals the Impact of Drug Rebates on Formulary Design in Medicare Part D module”, Mert Demirer, Alexander L. Olssen's, https://mitsloan.mit.edu/centers-initiatives/hsi/recent-research-reveals-impact-drug-rebates-formulary-design-medicare-part-d-module.

7. “Assessing postsale rebates for prescription drugs in Medicare”, 2023, https://www.medpac.gov/wp-content/uploads/2023/06/Jun23_Ch2_MedPAC_Report_To_ Congress_SEC.pdf.

8. “Pharmacy Benefit Managers, Rebates, and Drug Prices: Conflicts of Interest in the Market for Prescription Drugs”, Joanna Shepherd, 2020, https://openyls.law.yale.edu/server/api/ core/bitstreams/fc20e184-b2d6-4b02-a0f6-a495e3fb5cd2/content.

9. “Estimating Demand with Unobserved No-Purchases on Revenue-Managed Data”, Anran Li, Kalyan Talluri, , Müge Tekin, 27 Nov 2024, https://doi.org/10.1287/msom.2021.0291.

10. “Identification and estimation of dynamic structural models with unobserved choices”, Yingyao Hu, Yi Xin, June 2024, https://doi.org/10.1016/j.jeconom.2024.105806.

11. “Average pharmaceutical rebate percentages (%) per financial year”, 22 December 2021, https://www.pharmac.govt.nz/news-and-resources/official-information-act/official-information-act-responses/average-pharmaceutical-rebate-percentages-per-financial-year.

12. “BI Project Management Part 2 – The Agile Approach to Business Intelligence”, 17 Aug 2022, https://www.clearpeaks.com/bi-project-management-part-2-the-agile-approach-to-business-intelligence/.

Downloads

Published

2025-01-10

How to Cite

ETL-Driven Data Integration for Enhanced Pharmaceutical Manufacturer Rebate Processing. (2025). International Journal of Advanced Research in Computer Science & Technology(IJARCST), 8(1), 11606-11615. https://doi.org/10.15662/9cfsb587